ChromaDex Corp. CDXC Cash Flow

Chromadex corp. (CDXC)

CashFlow / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11
Cash Flows From Operating Activities
Net loss
-5,902	-8,853	-7,202	-7,755	-8,337	-8,218	-8,605	-8,050	-8,443	-	-8,822	2,137	-2,764	-1,929	-2,146	-954	-82	255	-1,426	-3	-315	-1,025	-1,227	-659	-1,653	-1,848	-724	-1,250	-1,020	-1,424	-1,698	-1,538	-3,993	-4,431	-2,491	-2,404	-1,842	-1,156
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation of leasehold improvements and equipment
214	203	196	190	173	171	169	146	121	-	114	132	135	129	97	75	76	82	75	72	70	66	61	54	55	50	58	53	55	79	80	80	81	85	81	81	83	81
Amortization of intangibles
62	62	62	61	61	60	59	58	58	-	58	58	66	24	24	24	27	11	12	11	10	10	10	9	8	7	6	6	5	4	4	4	3	3	14	18	18	18
Amortization of right of use assets
92	92	144	141	138	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Amortization of right of use assets
-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Share-based compensation
1,873	1,698	1,686	1,759	2,029	1,985	1,317	1,811	1,258	-	3,394	491	400	320	263	272	333	324	321	433	507	715	449	431	1,036	999	228	331	376	351	-	-	-	-	-	-	-	-
Allowance for doubtful trade receivables
-2,708	2,232	4	-13	5	0	-5	-15	-112	-	137	-204	-341	-3	477	205	58	-28	324	2	-10	13	-	8	9	7	-	-	-	-	-	-	-	-	-	-	-	-
Share-based compensation expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	513	925	1,198	65	499	964	768	737
Loss from disposal of equipment
-	-	-	-	-	0	0	0	-1	-	0	-4	-1	0	-	-	-	-	-	-	-	-	-	0	-17	-0	-	0	0	0	0	0	0	1	0	0	0	0
Non-cash financing costs
-	-	-	-	-	-	-	-	-	-	-	-	-	25	16	0	40	53	48	47	45	46	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Non-cash financing costs
-23	11	123	0	0	0	0	38	32	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss from investment in affiliate
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-24	0	0	-21	-11	-33	0	0	-	-	-	-	-	-	-	-
Changes in operating assets and liabilities:
Changes in operating assets and liabilities:
Trade receivables
-1,326	1,546	-217	-2,329	956	414	362	-344	679	-	-555	-136	806	822	181	76	-2,522	-1,850	1,009	-687	-854	-341	2,810	-415	-462	-835	-2,491	160	-200	971	-737	-215	412	-676	-74	512	-396	236
Contract assets
0	89	-37	-12	16	21	-14	-10	3	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Contract assets
-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other receivable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-430	0	0	215	215	0	0	0	-	-	-	-	-	-	-	-
Inventories
-255	-1,716	895	-2,886	421	-1,171	-552	-1,463	733	-	819	1,179	1,144	-965	-1,599	-1,788	2,164	1,464	-4,010	-1,074	142	502	1,612	586	-380	-288	946	-273	-371	164	231	-182	-1,202	-1,145	-404	-1,629	668	-116
Prepaid expenses and other assets
-252	73	-370	-90	140	118	32	282	-367	-	184	75	-460	-95	96	36	-280	14	4	48	-52	-81	178	8	27	-123	113	0	35	-86	31	274	-149	519	-291	-810	472	-43
Accounts payable
-1,467	3,457	-3,155	-430	206	655	2,136	900	2,138	-	-629	1,215	-4,733	1,783	1,879	1,767	-573	-3,318	2,663	466	453	-810	1,189	-478	964	481	-906	195	-224	-683	589	-562	334	816	943	-50	376	466
Accrued expenses
833	722	52	-950	279	726	-97	-25	64	-	1,516	18	118	-180	460	-227	586	47	87	-66	278	149	-4	119	6	74	-277	222	-77	-72	196	122	-314	101	43	168	75	97
Deferred revenue
0	0	0	-89	3,962	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Customer deposits and other
69	-92	-32	-70	88	119	-29	-17	-4	-	-7	-176	105	10	111	14	-76	67	35	7	-164	158	8	-37	-125	-157	-113	322	22	4	53	87	-50	20	-40	80	-35	81
Principal payments on operating leases
143	-141	-203	-404	119	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred rent
-	-	-	-	-	-16	-8	76	-50	-	-8	168	-20	40	321	75	125	-18	-18	-18	-17	-14	-14	-14	-12	-9	11	42	18	-15	-14	-14	-14	-15	-15	-9	-8	-1
Due to officer
-	-	-	-	-	0	0	0	-100	-	0	-1	0	-32	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash used in operating activities
-5,221	-610	-7,760	-9,021	-3,048	-5,136	-5,235	-6,548	-3,989	-	-3,767	-475	-5,511	-51	191	-140	-91	-2,896	-853	-760	93	-591	-245	-386	-543	-1,404	-1,732	-87	-1,380	-705	-749	-1,018	-3,695	-4,656	-1,601	-1,437	-1,307	247
Cash Flows From Investing Activities
Proceeds from disposal of assets held at escrow
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	-19	1	0	17	-20	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Purchases of leasehold improvements and equipment
15	280	155	69	239	10	37	1,113	161	-	295	577	133	162	563	709	214	16	282	103	43	95	69	30	8	14	19	78	31	7	10	1	7	4	24	23	44	58
Purchases of intangible assets
0	0	0	0	10	86	45	0	0	-	0	0	0	184	15	10	180	15	15	85	17	5	40	20	65	5	20	29	0	40	0	50	0	2	0	11	15	0
Investment in other long-term assets
5	1	1	0	47	323	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from sales of assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	1	0	250	250	500	0	0	0	0	-	-	-	-
Proceeds from sales of equipment
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	-	-	-	-	-	-	-	-
Proceeds from investment in affiliate
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	749	0	0	1,092	0	225	0	0	-	-	-	-	-	-	-	-
Net cash used in investing activities
-20	272	-156	-69	-296	-419	-82	-1,113	-161	-	-295	5,376	-133	-346	-578	-719	-394	-31	-297	-188	-60	-100	639	-50	-73	1,074	-39	367	218	452	-10	-51	-7	-6	-24	-34	-59	-58
Cash Flows From Financing Activities
Proceeds from exercise of stock options
132	460	335	164	107	9	190	75	255	-	2,643	383	5	7	0	94	528	93	69	9	15	0	17	404	17	27	0	6	125	6	0	3	0	0	0	0	7	19
Proceeds from issuance of common stock, net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-2	5,240	480	1,974	0	0	0	-	-	-	-	-	-	-	-	70	1	88	10,070	0	0	0	0
Proceeds from exercise of warrants
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	921	716	0	112	45	0	0	1,516	527	479
Payment of debt issuance cost
15	113	0	0	0	0	0	13	6	-	26	7	42	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Principal payments on loan payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	4,853	146	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Repurchase of common stock, amount
-	-	-	-	-	0	0	0	-404	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Principal payments on finance leases
80	75	73	76	52	52	48	49	47	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Principal payments on capital leases
-	-	-	-	-	-	-	-	-	-	46	424	71	67	57	55	54	53	52	51	50	57	48	44	44	33	33	26	24	23	18	23	22	22	23	19	19	18
Net cash provided by financing activities
37	271	7,035	9,523	55	-43	142	13	-202	-	25,451	4,960	18,598	-60	-234	-245	860	373	1,992	-41	2,450	-57	2,366	359	-26	-6	2,946	-19	1,021	699	43	93	110	10,047	-23	1,496	515	480
Net decrease in cash
-5,204	-67	-881	433	-3,289	-5,598	-5,175	-7,648	-4,352	-	21,389	9,861	12,954	-457	-622	-1,105	374	-2,554	841	-990	2,483	-748	2,760	-76	-643	-336	1,173	260	-139	446	-717	-975	-3,592	5,385	-1,649	24	-850	669
Cash Beginning of Period
-	-	-	-	-	-	-	-	-	-	-	-	-	1,642	-	0	0	5,549	-	0	0	3,964	-	0	0	2,261	-	0	0	520	0	0	0	420	-	-	-	-
Supplemental Disclosures of Cash Flow Information
Cash payments for interest on finance leases
6	7	9	10	7	8	11	10	12	-	13	17	14	13	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Supplemental Schedule of Noncash Investing Activity
Cash payments for interest
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	104	135	-	220	0	73	40	12	12	9	9	8	8	7	6	6	7	8	7	7	8	8
Supplemental Schedule of Noncash Investing Activity
Financing lease obligation incurred for purchase of computer equipment
47	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Supplemental Schedule of Noncash Operating Activity
Adjustment to retained earnings: cumulative effect of initially applying ASC 606
-	-	-	-	-	-	0	0	164	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating lease obligation incurred for tenant improvement credit received
0	-2	0	0	64	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Noncash consideration transferred for the acquisition of Healthspan Research LLC
-	-	-	-	-	-	-	-	-	-	0	0	0	1,187	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Capital lease obligation incurred for purchases of equipment
-	-	-	-	-	-	-	-	-	-	0	283	123	109	156	0	0	0	0	0	0	303	0	100	222	0	130	0	55	116	18	0	0	50	47	0	0	0
Inventory supplied to Healthspan Research, LLC for equity interest, at cost
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	20	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retirement of fully depreciated equipment - cost
-	-	-	-	-	-	-	-	-	-	1	0	41	15	62	0	1	26	113	8	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retirement of fully depreciated equipment - accumulated depreciation
-	-	-	-	-	-	-	-	-	-	-1	0	-41	-15	-62	0	-1	-26	-113	-8	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Stock awards issued for services rendered in prior period
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-14	-	-	-	-	-	-	-	-
Stock awards issued for services prior to the period
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-
Changes in prepaid expenses associated with share-based compensation
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	5	49	-87	-87	24	182	23	0	0	0	-	-	-	-
Assets transferred
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-3,526	0	0	0	0	-	-	-	-
Liabilities transferred
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	737	0	0	-368	0	0	0	0	-	-	-	-
Carrying value of long-term investment in affiliate, net of $500,000 cash proceeds and $500,000 receivable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2,157	0	0	0	0	-	-	-	-